Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kymera Therapeutics (KYMR) Return on Assets (2020 - 2025)

Kymera Therapeutics (KYMR) has disclosed Return on Assets for 6 consecutive years, with 0.25% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets rose 1.0% to 0.25% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.25%, a 1.0% increase, with the full-year FY2025 number at 0.26%, up 8.0% from a year prior.
  • Return on Assets was 0.25% for Q4 2025 at Kymera Therapeutics, up from 0.3% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.06% in Q4 2021 to a low of 0.33% in Q3 2023.
  • A 5-year average of 0.22% and a median of 0.25% in 2025 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: decreased -20bps in 2022, then increased 11bps in 2024.
  • Kymera Therapeutics' Return on Assets stood at 0.06% in 2021, then crashed by -328bps to 0.26% in 2022, then decreased by -13bps to 0.29% in 2023, then increased by 11bps to 0.26% in 2024, then increased by 6bps to 0.25% in 2025.
  • Per Business Quant, the three most recent readings for KYMR's Return on Assets are 0.25% (Q4 2025), 0.3% (Q3 2025), and 0.3% (Q2 2025).